These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 10402106

  • 1. Statin + fibrate combination therapy fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular disease.
    Papadakis JA, Ganotakis ES, Jagroop IA, Winder AF, Mikhailidis DP.
    Int J Cardiol; 1999 Jun 01; 69(3):237-44. PubMed ID: 10402106
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of fluvastatin and bezafibrate in patients with hyperlipidemia and persistently high triglyceride levels.
    Spieker LE, Noll G, Hannak M, Lüscher TF.
    J Cardiovasc Pharmacol; 2000 Mar 01; 35(3):361-5. PubMed ID: 10710119
    [Abstract] [Full Text] [Related]

  • 3. Statin + fibrate combination therapy--fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular disease.
    Wray R, Hemsley D.
    Int J Cardiol; 1999 Dec 01; 71(3):291. PubMed ID: 10636539
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of a combination fluvastatin-bezafibrate treatment for familial hypercholesterolemia: comparative analysis with a fluvastatin-cholestyramine combination.
    Leitersdorf E, Muratti EN, Eliav O, Meiner V, Eisenberg S, Dann EJ, Sehayek E, Peters TK, Stein Y.
    Am J Med; 1994 May 01; 96(5):401-7. PubMed ID: 8192170
    [Abstract] [Full Text] [Related]

  • 5. Serum lipid comparison in patients treated by statins or fibrates: existence of bad HDL-C responders to statins.
    Devroey D, Velkeniers B, Duquet W, Betz W.
    Acta Cardiol; 2003 Jun 01; 58(3):179-84. PubMed ID: 12846506
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of a combination of fluvastatin and bezafibrate in patients with mixed hyperlipidaemia (FACT study).
    Pauciullo P, Borgnino C, Paoletti R, Mariani M, Mancini M.
    Atherosclerosis; 2000 Jun 01; 150(2):429-36. PubMed ID: 10856536
    [Abstract] [Full Text] [Related]

  • 7. Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study.
    Aguilar-Salinas CA, Fanghänel-Salmón G, Meza E, Montes J, Gulías-Herrero A, Sánchez L, Monterrubio-Flores EA, González-Valdez H, Gómez Pérez FJ.
    Metabolism; 2001 Jun 01; 50(6):729-33. PubMed ID: 11398153
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of triple therapy (fluvastatin-bezafibrate-cholestyramine) for severe familial hypercholesterolemia.
    Leitersdorf E, Muratti EN, Eliav O, Peters TK.
    Am J Cardiol; 1995 Jul 13; 76(2):84A-88A. PubMed ID: 7604807
    [Abstract] [Full Text] [Related]

  • 9. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1996 Jan 13; 77A():28-32. PubMed ID: 8729588
    [Abstract] [Full Text] [Related]

  • 10. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1994 Dec 13; (77):28-32. PubMed ID: 19496270
    [Abstract] [Full Text] [Related]

  • 11. Treatment of primary hypercholesterolemia: fluvastatin versus bezafibrate.
    Greten H, Beil FU, Schneider J, Weisweiler P, Armstrong VW, Keller C, Klör HU, von Hodenberg E, Weidinger G, Eskötter H.
    Am J Med; 1994 Jun 06; 96(6A):55S-63S. PubMed ID: 8017468
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia.
    Bruckert E, De Gennes JL, Malbecq W, Baigts F.
    Clin Cardiol; 1995 Nov 06; 18(11):621-9. PubMed ID: 8590530
    [Abstract] [Full Text] [Related]

  • 13. Comparative efficacy and safety of ciprofibrate and sustained-release bezafibrate in patients with type II hyperlipidaemia.
    Betteridge DJ, O'Bryan-Tear CG.
    Postgrad Med J; 1996 Dec 06; 72(854):739-43. PubMed ID: 9015467
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
    Mendoza S, Gamez R, Mas R, Goicochea E.
    Int J Tissue React; 2003 Dec 06; 25(3):81-9. PubMed ID: 14756189
    [Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia.
    Athyros VG, Papageorgiou AA, Hatzikonstandinou HA, Didangelos TP, Carina MV, Kranitsas DF, Kontopoulos AG.
    Am J Cardiol; 1997 Sep 01; 80(5):608-13. PubMed ID: 9294990
    [Abstract] [Full Text] [Related]

  • 18. Differential associations of statin and fibrate treatment with carotid arterial remodeling.
    Chironi G, Simon A, Gariepy J, Balice M, Del-Pino M, Levenson J.
    Am J Hypertens; 2005 Nov 01; 18(11):1476-81. PubMed ID: 16280285
    [Abstract] [Full Text] [Related]

  • 19. Effects of simvastatin and ciprofibrate alone and in combination on lipid profile, plasma fibrinogen and low density lipoprotein particle structure and distribution in patients with familial combined hyperlipidaemia and coronary artery disease.
    Kontopoulos AG, Athyros VG, Papageorgiou AA, Hatzikonstandinou HA, Mayroudi MC, Boudoulas H.
    Coron Artery Dis; 1996 Nov 01; 7(11):843-50. PubMed ID: 8993943
    [Abstract] [Full Text] [Related]

  • 20. Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT study). Fluvastatin Alone and in Combination Treatment.
    Cortellaro M, Cofrancesco E, Boschetti C, Cortellaro F, Mancini M, Mariani M, Paoletti R.
    Thromb Haemost; 2000 Apr 01; 83(4):549-53. PubMed ID: 10780315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.